HAPA pharm

News 1

[PRESS RELEASE] Standardized medical cannabis for greater patient safety

Düsseldorf, September 2023 – expopharm, Europe’s leading trade fair for the pharmaceutical market, is once again the central meeting place for industry insiders in Düsseldorf this year. In addition to a comprehensive range of pharmaceutical products and services, this year HAPA pharm presented its innovative dosage forms for medicinal cannabis developed with pharmacists, including inhalation

Weiterlesen »
News 2

HAPA Joins the European Medicinal Cannabis Association

We are excited to announce that HAPA is now a member of the European Medicinal Cannabis Association (EUMCA). The EUMCA is the authoritative voice for the medicinal cannabis industry sector in Europe, and we are proud to now be a part of this important organization. Sita Schubert, the founder and general secretary of the EUMCA,

Weiterlesen »
News 3


Dear Investors, we appreciate your continued support and interest in HAPA pharm. We are pleased to share with you the latest developments of our company and our future plans.

Weiterlesen »
News 4

Raphael Mechoulam – pioneer of cannabis research

Raphael Mechoulam was born in Sofia, Bulgaria, on November 5, 1930. The son of Jewish immigrants from Bulgaria, he grew up in Israel. He studied at the Hebrew University of Jerusalem, where he later began his career as a scientist. After completing his studies in 1952, Mechoulam worked as an officer in the Israeli army

Weiterlesen »
News 5

HAPA introduces Alexander Rieg as new chief operating officer.

Dortmund, January 2023 – HAPA Pharm GmbH is expanding its management team: from January 2023, industry pioneer Alexander Rieg will support the internationally active company as Chief Operating Officer. Alexander Rieg has been an integral part of the medical cannabis industry in Germany for years. Not only is he the founder of `GECA Pharma GmbH’,

Weiterlesen »
News 6

HAPA pharm receives GMP certification

HAPA pharm (“HAPA” or the “Company”) operates production facilities in North Macedonia to grow and process medical cannabis for the sale of pharmaceutical cannabis flos and extracts. On May 1st 2020, the Company has successfully received GMP (Good Manufacturing Practice) approval for both facilities.This milestone demonstrates HAPA’s commitment towards stringent quality assurance on premises and

Weiterlesen »
Scroll to Top


This content is currently only available in German.

Lieber Arzt, Lieber Apotheker,

im Passwort-geschützten Bereich unserer Website haben wir zahlreiche wertvolle Artikel für Sie zur Verfügung gestellt. Unter anderem finden Sie Informationen zu folgenden Themen: 

  • Verschreibung & Erstattung, GOP
  • Antragstellung Krankenkasse (was Sie Ihren Patienten unbedingt mitteilen sollen)
  • Produktübersicht
  • Dosisfindung
Skip to content